跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENEST 30 ED levonorgestrel/ ethinylestradiol 150 micrograms/30 micrograms tablet composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
LENEST 30 ED levonorgestrel/ ethinylestradiol 150 micrograms/30 micrograms tablet composite pack
Approved
STANDARD
LENEST 30 ED levonorgestrel/ ethinylestradiol 150 micrograms/30 micrograms tablet composite pack
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b4f1bd0039a2f240
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
b4f1bd0039a2f240
Product Name
LENEST 30 ED levonorgestrel/ ethinylestradiol 150 micrograms/30 micrograms tablet composite pack
Artg Id
233113
Artg Name
LENEST 30 ED levonorgestrel/ ethinylestradiol 150 micrograms/30 micrograms tablet composite pack
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2015-11-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-01547-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-02718-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b4f1bd0039a2f240
Type
Standard
Back to TGA Approvals